ATE535199T1
Compositions and devices for reducing the mineral content of vascular calcified lesions
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 14 July 2019, 7.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
64 members in 8 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 11819398 | United States of America | A | |
| 19529198 | United States of America | A |
Members64
| Document | Office | Kind | |
|---|---|---|---|
| CA2337113A1 | Canada | A1 | |
| WO0003651A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5101699A | Australia | A | |
| CA2382351A1 | Canada | A1 | |
| WO0115767A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6936600A | Australia | A | |
| EP1100392A1 | European Patent Office (EPO) | A1 | |
| US6290689B1 | United States of America | B1 | |
| CA2403533A1 | Canada | A1 | |
| WO0170320A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4546801A | Australia | A | |
| US2001039411A1 | United States of America | A1 | |
| US2001041865A1 | United States of America | A1 | |
| US2002044907A1 | United States of America | A1 | |
| US6379345B1 | United States of America | B1 | |
| US6387071B1 | United States of America | B1 | |
| US6394096B1 | United States of America | B1 | |
| EP1229959A1 | European Patent Office (EPO) | A1 | |
| US6488671B1 | United States of America | B1 | |
| EP1229959A4 | European Patent Office (EPO) | A4 | |
| US2003018297A1 | United States of America | A1 | |
| US6527979B2 | United States of America | B2 | |
| US6533767B2 | United States of America | B2 | |
| EP1294422A1 | European Patent Office (EPO) | A1 | |
| US6562020B1 | United States of America | B1 | |
| US2003104073A1 | United States of America | A1 | |
| JP2003522560A | Japan | A | |
| JP2003527225A | Japan | A | |
| US6622732B2 | United States of America | B2 | |
| US2003199820A1 | United States of America | A1 | |
| US2004077992A1 | United States of America | A1 | |
| US6730063B2 | United States of America | B2 | |
| EP1100392A4 | European Patent Office (EPO) | A4 | |
| US2005059955A1 | United States of America | A1 | |
| US2006161099A1 | United States of America | A1 | |
| US2006161103A1 | United States of America | A1 | |
| US7141045B2 | United States of America | B2 | |
| EP1294422A4 | European Patent Office (EPO) | A4 | |
| US2007173784A1 | United States of America | A1 | |
| EP1100392B1 | European Patent Office (EPO) | B1 | |
| AT423519T | Austria | T | |
| ATE423519T1 | Austria | T1 | |
| DE69940471D1 | Germany | D1 | |
| EP2055249A1 | European Patent Office (EPO) | A1 | |
| EP1229959B1 | European Patent Office (EPO) | B1 | |
| AT431172T | Austria | T | |
| ATE431172T1 | Austria | T1 | |
| CA2337113C | Canada | C | |
| DE60042213D1 | Germany | D1 | |
| EP2075031A1 | European Patent Office (EPO) | A1 | |
| EP1294422B1 | European Patent Office (EPO) | B1 | |
| AT458525T | Austria | T | |
| ATE458525T1 | Austria | T1 | |
| DE60141400D1 | Germany | D1 | |
| EP2241271A1 | European Patent Office (EPO) | A1 | |
| EP2241271B1 | European Patent Office (EPO) | B1 | |
| AT527943T | Austria | T | |
| ATE527943T1 | Austria | T1 | |
| JP4804693B2 | Japan | B2 | |
| EP2055249B1 | European Patent Office (EPO) | B1 | |
| AT535199T | Austria | T | |
| ATE535199T1This record | Austria | T1 | |
| US8500683B2 | United States of America | B2 | |
| CA2403533C | Canada | C |
Numbers
- Application
- 9000125
Titles2
- German
- FLUIDEN UND VORRICHTUNGEN ZUR REDUZIERUNG DES MINERALGEHALTS VON VERKALKTEN VASKULÄREN LÄSIONEN
- English
- FLUID AND DEVICES FOR REDUCING THE MINERAL CONTENT OF CALCIFIED VASCULAR LESIONS
Classification
- CPC, 3
- A61B17/22
- A61B2017/22084
- A61B2017/22098
- IPC, 1
- A61B17 22